PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2013.28.4.2832013284283Association of Serum Adipocyte-Specific Fatty Acid Binding Protein with Fatty Liver Index as a Predictive Indicator of Nonalcoholic Fatty Liver DiseaseWon Seon Jeon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Leehttps://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2013.28.4.283, https://synapse.koreamed.org/pdf/10.3803/EnM.2013.28.4.283, http://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2013.28.4.283
Liver International10.1111/liv.140212018Serum adipocyte fatty acid‐binding protein levels: an indicator of non‐alcoholic fatty liver disease in Chinese individualsYiting Xu, Xiaojing Ma, Xiaoping Pan, Xingxing He, Yufei Wang, Yuqian Baohttps://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14021, https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14021
The Journal of Nutritional Biochemistry10.1016/j.jnutbio.2010.02.0072011223289-292Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjectsYoung-Choon Kim, Yong-Kyun Cho, Won-Young Lee, Hong-Joo Kim, Jung-Ho Park, Dong-Il Park, Chong-Il Sohn, Woo-Kyu Jeon, Byung-Ik Kim, Se-Eun Parkhttps://api.elsevier.com/content/article/PII:S0955286310000653?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0955286310000653?httpAccept=text/plain
Hepatology10.1002/hep.2289620094961926-1934Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver diseaseKerry-Lee Milner, David van der Poorten, Aimin Xu, Elisabetta Bugianesi, James G. Kench, Karen S. L. Lam, Donald J. Chisholm, Jacob Georgehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22896, https://onlinelibrary.wiley.com/doi/full/10.1002/hep.22896
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.66/fullpdf
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.880412019Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?Emad Hamdy Gad, Yasmin Kamelhttp://www.intechopen.com/download/pdf/68011
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loombahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.65, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.65/fullpdf
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.857802019The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaZaki A. Sherifhttp://www.intechopen.com/download/pdf/68253
Clinical Liver Disease10.1002/cld.722201811481-81The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseaseshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.722, https://onlinelibrary.wiley.com/doi/full/10.1002/cld.722
Liver Transplantation10.1002/lt.220042009164431-439Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver diseaseKanthi Yalamanchili, Sherif Saadeh, Göran B. Klintmalm, Linda W. Jennings, Gary L. Davishttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.22004, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.22004, http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.22004/fullpdf